📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: GlobeImmune

1.1 - Company Overview

GlobeImmune Logo

GlobeImmune

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of a proprietary Tarmogen® platform used to develop products for the treatment of cancer and infectious diseases.

Products and services

  • Cancer Treatment Products: Engineers platform-based therapeutics using the Tarmogen® technology to construct products specifically intended for the treatment of cancer
  • Infectious Disease Treatment Products: Architects platform-based therapeutics using the Tarmogen® technology to build products specifically intended for the treatment of infectious diseases
  • Tarmogen® Platform: Proprietary technology platform used to develop products for the treatment of cancer and infectious diseases

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to GlobeImmune

Xenikos Logo

Xenikos

HQ: The Netherlands Website
  • Description: Provider of antibody-based immunotherapies, developing a combination of two toxin-loaded anti-T-cell antibodies to quickly reset the immune system in patients with serious immune diseases or transplant rejection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Xenikos company profile →
Enumeral Biomedical Logo

Enumeral Biomedical

HQ: United States Website
  • Description: Provider of a nanotechnology-enabled process for therapeutic discovery, immune profiling, and personalized medicine.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Enumeral Biomedical company profile →
Theravectys Logo

Theravectys

HQ: France Website
  • Description: Provider of a proprietary lentiviral vector platform for developing vaccines and immunotherapies to prevent and treat infectious diseases, cancers, and other conditions. Pipeline includes Lenti-HPV-07 (Phase 1) for HPV16/18-induced oropharyngeal and cervical cancers, Lenti-COVID intranasal vaccine for SARS-CoV-2 variants, and LV-DEN tetravalent T-cell dengue vaccine. Initial clinical focus includes HIV/AIDS.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Theravectys company profile →
Apthera Logo

Apthera

HQ: United States Website
  • Description: Provider of peptide-based cancer immunotherapy solutions for the treatment of breast and prostate cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apthera company profile →
Scancell Logo

Scancell

HQ: United Kingdom Website
  • Description: Provider of immunotherapy platforms and therapeutic vaccines for cancer and infectious diseases, including ImmunoBody and Moditope for cancer vaccines, GlyMab for glycan-targeting monoclonal antibodies, AvidiMab to enhance antibody potency and tumor specificity, and melanoma vaccines SCIB1 and iSCIB1+.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Scancell company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for GlobeImmune

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to GlobeImmune

2.2 - Growth funds investing in similar companies to GlobeImmune

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for GlobeImmune

4.2 - Public trading comparable groups for GlobeImmune

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to GlobeImmune

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About GlobeImmune

What does GlobeImmune do?

GlobeImmune is a provider of a proprietary Tarmogen® platform used to develop products for the treatment of cancer and infectious diseases.

Who are GlobeImmune's competitors?

GlobeImmune's competitors and similar companies include Xenikos, Enumeral Biomedical, Theravectys, Apthera, and Scancell.

Where is GlobeImmune headquartered?

GlobeImmune is headquartered in United States.

How many employees does GlobeImmune have?

GlobeImmune has 1,000 employees 🔒.

When was GlobeImmune founded?

GlobeImmune was founded in 2010 🔒.

What sector and industry vertical is GlobeImmune in?

GlobeImmune is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for GlobeImmune

Who are the top strategic acquirers in GlobeImmune's sector and industry

Top strategic M&A buyers and acquirers in GlobeImmune's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for GlobeImmune?

Top strategic M&A buyers groups and sectors for GlobeImmune include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in GlobeImmune's sector and industry vertical

Which are the top PE firms investing in GlobeImmune's sector and industry vertical?

Top PE firms investing in GlobeImmune's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in GlobeImmune's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in GlobeImmune's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in GlobeImmune's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to GlobeImmune include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in GlobeImmune's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for GlobeImmune?

The key public trading comparables and valuation benchmarks for GlobeImmune include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for GlobeImmune for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for GlobeImmune with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in GlobeImmune's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for GlobeImmune with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in GlobeImmune's' sector and industry vertical?

Access recent funding rounds and capital raises in GlobeImmune's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for GlobeImmune